Related Experiment Video
Updated: Sep 1, 2025

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Mechanistic insight toward EGFR activation induced by ATP: role of mutations and water in ATP binding patterns
Emiliano Laudadio1, Giovanna Mobbili2, Leonardo Sorci1
1Department of Science and Engineering of Matter, Environment and Urban Planning, Marche Polytechnic University, Ancona, Italy.
Abstract:
The discovery of mutations within the kinase domain of the epidermal growth factor receptor (EGFR) gene has enabled a new era of targeted therapy in non-small cell lung cancer (NSCLC). Drugs belonging to the family of tyrosine kinase inhibitors (TKIs) are designed to bind ATP binding cleft, anyway, the occurrence of aminoacidic mutations decreases the effectiveness of the antitumoral treatment. Despite many efforts has been already made, the impact of the mutations on conformation and stability of EGFR-ATP complexes is still not fully understood. Therefore, we investigated the effect of mutations that leads to changes in Michaelis-Menten constant (Km) using dynamic docking simulations. We focused on six different EGFR forms in relation to different mutation states, then we found a good correlation between the calculated ATP affinities and Km values. Moreover, since dynamic switching of TK-EGFR from the inactive towards the active state is known to regulate the kinase activity, we observed that ATP induces the inwards movement of the αC-helix with the Lys745 close to Glu762 in all cases. This means that ATP binding should be the first step in promoting the conformational shift to the active state. Finally, we highlighted for the first time the key contribution of water hydrogen bond and water-bridge networks in the modulation of ATP affinity. The identified mutant-specific ATP binding patterns and conformational features could be much useful to guide cancer therapy and develop more personalized medicine. Communicated by Ramaswamy H. Sarma.
Insights
Mutations in epidermal growth factor receptor (EGFR) impact targeted cancer therapy effectiveness. This study reveals how these mutations affect EGFR-ATP binding and conformation, aiding personalized medicine for non-small cell lung cancer (NSCLC).
Area of Science:
- Molecular Biology
- Biochemistry
- Computational Chemistry
Background:
- Mutations in the epidermal growth factor receptor (EGFR) kinase domain are crucial for targeted therapy in non-small cell lung cancer (NSCLC).
- Tyrosine kinase inhibitors (TKIs) targeting the ATP binding cleft are less effective due to these mutations, and their precise impact on EGFR-ATP complex stability and conformation remains unclear.
Purpose of the Study:
- To investigate the effect of EGFR mutations on ATP binding affinity and complex conformation using dynamic docking simulations.
- To correlate computational findings with experimental Michaelis-Menten constant (Km) values.
- To elucidate the role of water molecules in modulating ATP affinity in wild-type and mutant EGFR.
Main Methods:
- Dynamic docking simulations were performed on six different EGFR forms representing various mutation states.
- ATP binding affinities were calculated and correlated with experimentally determined Km values.
- Conformational changes, including the movement of the αC-helix and the role of water-mediated hydrogen bonds, were analyzed.
Main Results:
- A strong correlation was observed between calculated ATP affinities and Km values across different EGFR mutations.
- ATP binding was found to induce an inward movement of the αC-helix, positioning Lys745 near Glu762, indicating ATP binding as an initial step towards the active state.
- Water hydrogen bonds and water-bridge networks were identified as critical modulators of ATP affinity, with distinct patterns observed in mutant EGFR forms.
Conclusions:
- EGFR mutations significantly alter ATP binding patterns and conformational dynamics.
- Understanding these mutant-specific interactions is vital for guiding the development of more personalized and effective cancer therapies.
- The findings provide a molecular basis for rational drug design and improved treatment strategies for NSCLC patients.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
08:31Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
Related Concept Videos
Mitogens and the Cell Cycle
ATP Synthase: Mechanism
The Ras Gene
Ras is a...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity: